TG Therapeutics Inc
NASDAQ:TGTX

Watchlist Manager
TG Therapeutics Inc Logo
TG Therapeutics Inc
NASDAQ:TGTX
Watchlist
Price: 32.1729 USD -0.08%
Market Cap: 5B USD
Have any thoughts about
TG Therapeutics Inc?
Write Note

EV/S
Enterprise Value to Sales

18.4
Current
77.8
Median
7.5
Industry
Lower than median
Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
18.4
=
Enterprise Value
4.9B USD
/
Revenue
264.8m USD
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
14.5
2-Years Forward
EV/S
8.8
3-Years Forward
EV/S
6.4

See Also

Discover More